Menu
Search
Home > Courses > Best of ACTHIV 2020: Sex in the City (and in the Country): Diagnosis & Treatment of STIs

Best of ACTHIV 2020: Sex in the City (and in the Country): Diagnosis & Treatment of STIs

Best of ACTHIV 2020: Sex in the City (and in the Country): Diagnosis & Treatment of STIs
Play
Sorry, this learning module is not available for mobile devices.
ACTHIV
Original Release Date: 8/22/2020
Termination Date: 12/31/2021
Review Date: 12/31/2020
Presenter
  • Jeanne Marrazzo, MD, MPH, FACP, FIDSA
    Professor of Medicine, Director of the Division of Infectious Diseases
    University of Alabama at Birmingham
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Name at least three sexually transmitted infections that are disproportionately affecting persons living with HIV.
  2. Identify the most effective means to treat gonorrhea in the era of increasing antimicrobial resistance.
  3. Describe the current epidemiology of congenital syphilis in the United States and its threat to women living with HIV.
Presenter Bio
Jeanne Marrazzo, MD, MPH, FACP, FIDSA
Jeanne Marrazzo, MD, MPH, FACP, FIDSA is Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham. She is internationally recognized for her research and education efforts in the field of sexually transmitted infections, especially as they affect women’s health and in the setting of HIV. She is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America (IDSA), and was elected to the IDSA Board of Directors in 2018. She was Chair of the American Board of Internal Medicine Council from 2015-2018. Dr. Marrazzo conducts research on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception, and its relationship to women’s risk of STI/HIV acquisition. She was the Protocol Co-Chair for the VOICE Study (MTN-003), a placebo-controlled trial that randomized over 5,000 women in South Africa, Uganda, and Zimbabwe to oral or vaginal tenofovir-based HIV pre-exposure prophylaxis. She chairs the Biomedical Science Committee of the HIV Prevention Trial Network, the group tasked with integrating the biomedical science agenda across numerous clinical trials of antiretroviral prevention agents. She is also the Principal Investigator of the NIH-funded STI Clinical Trials Group and Co-PI of the Leadership Group of the Vaccine Treatment and Evaluation Unit.
Continuing Education Credit

The enduring material is jointly provided by Beaumont Health, American Academy of CME, Inc., and ACTHIV Institute.

The 14th Annual American Conference for the Treatment of HIV (ACTHIV) was held virtually August 20-22, 2020. The Conference was supported by the Clinical Education Initiative, New York State Department of Health, AIDS Institute. The conference and this Best of ACTHIV web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; and ViiV HealthCare.

ONLINE CE CREDIT:

To obtain online CE credit, please follow this link to the course evaluation.

FACULTY:

Jeanne Marrazzo, MD, MPH, FACP, FIDSA, Professor of Medicine, Director of the Division of Infectious Diseases, University of Alabama at Birmingham.

Estimated time to complete: 45 minutes

TARGET AUDIENCE

Members of the HIV care team who are frontline providers of care to persons at risk for or are living with HIV infection, including physicians (both specialists and primary care/family medicine), nurse practitioners, physician assistants, nurses, pharmacists, case managers and other care team members are also encouraged to participate.

Learning Objectives

As a result of participating in this activity, participants should be better able to:

  • Name at least three sexually transmitted infections that are disproportionately affecting persons living with HIV.
  • Identify the most effective means to treat gonorrhea in the era of increasing antimicrobial resistance.
  • Describe the current epidemiology of congenital syphilis in the United States and its threat to women living with HIV.

CREDIT

ACTHIV CME

In support of improving patient care, this activity has been planned and implemented by Beaumont Health, American Academy of CME, Inc., and the ACTHIV Institute. Beaumont Health is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians:

Beaumont Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACTHIV CME

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc., Beaumont Health, and the ACTHIV Institute. Beaumont Health is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses Practitioners and Nurses: 

American Academy of CME, Inc. designates this educational activity for 0.75 contact hours (0.75 pharmacotherapeutic contact hours).

Physician Assistants:

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until December 31, 2021. PAs should only claim credit commensurate with the extent of their participation.

All other members of the HIV Care team will receive a certificate of participation.

There is no fee to participate in this activity.

HOW TO RECEIVE CREDIT 

In order to obtain your certificate of credit, you must read the CME/CE information, review the full content of the activity, and complete the online evaluation.

Upon submission of the evaluation, your certificate for the activity will be made available immediately to print online.

DISCLOSURES

According to the disclosure policy of the Academy and Beaumont, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures will be made known to the participants prior to the activity. 

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy, Beaumont, or ACTHIV Institute. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Off-Label Usage Disclosure

This activity contains off-label discussion.

Faculty Disclosure

Jeanne Marrazzo MD, MPH : discloses the following relevant financial relationships with commercial interests: Advisory Board BD (Becton Dickinson); Grant/Research Support: BD.

Planner Disclosures

The following individuals have no relevant financial relationships with commercial interests to disclose: Julie Barroso, PhD, ANP, FAAN; John Brooks, MD; Sherrillyn Crooks, PA-C; Carlos del Rio, MD; Courtney V Fletcher, PharmD; John JD Juchniewicz, MCIS, CHCP; Bill G Kapogiannis, MD; Deborah Kim, RPh; H. Nina Kim, MD, MSc; Natalie Kirkwood, RN, BSN, JD; Harry Lampiris, MD; Sharon Lee, MD; Vincent Lo Re, MD, MSCE; Lorenzo McFarland, DHA, MPH, MSW, PMP; Edward Moylan, RP; Paul Miniter, MS; Asa Radix, MD, MPH; Dianne Rausch, PhD; Renslow Sherer, MD; Cheryl Smith, MD; Brooke Taylor, MPH, CHCP; Andrea Weddle, MSW; Susan Weiss, FNP-BC, MSN, AAHIVS; Barbara A. Young, MSW, LCSE, LCADC, SAC

The following individuals have relevant financial relationships with commercial interests to disclose:

Oluwatoyin Adeyemi, MD: Advisory Board: Gilead Sciences; Grant/Research Support: Gilead Sciences 
Roger Bedimo, MD: Advisory Board: Merck & Co. & Co., ViiV Healthcare; Grant/Research Support: ViiV Healthcare
Michelle Cespedes, MD, MS: Advisory Board: Gilead Sciences, ViiV Healthcare 
Eric Daar, MD: Advisory Board: Gilead Sciences, ViiV Healthcare; Grant/Research Support: Gilead Sciences, Merck & Co., ViiV Healthcare 
Donna Futterman, MD: Grant/Research Support: Gilead Sciences 
Rajesh Gandhi, MD: Advisory Board: Merck & Co. 
Margaret Hoffman-Terry, MD, FACP, AAHIVS: Advisory Board: ViiV Healthcare; Grant/Research Support: ViiV Healthcare; Speaker's Bureau: Gilead Sciences, ViiV Healthcare 
Tonia Poteat, PhD, PA-C: Advisory Board: Gilead Sciences; Grant/Research Support: Gilead Sciences, ViiV Healthcare  
Jennifer C. Price, MD, PhD: Advisory Board: Surrozen, Theratechnologies; Shareholder (Spouse/Partner): Abbvie, Merck & Co., Bristol-Myers Squibb, Johnson & Johnson; Grant/Research Support: Gilead Sciences, Merck & Co. 
Jason Schafer, PharmD, MPH: Advisory Board: Merck & Co.; Grant/Research Support: Merck & Co., Gilead Sciences 
William Short, MD, MPH: Advisory Board: ViiV Healthcare 
Babafemi Taiwo, MBBS: Advisory Board: ViiV Healthcare, Gilead Sciences, Merck & Co. 
Pablo Tebas, MD: Advisory Board: Merck & Co., ViiV Healthcare, Gilead Sciences; Grant/Research Support: Merck & Co., ViiV Healthcare, Gilead Sciences, Inovio, Genone
Melanie Thompson, MD: Grant/Research Support: Bristol-Myers Squibb, Cytodyn, Cepheid, Gilead Sciences, GlaxoSmithKline, Merck & Co., ViiV Healthcare 

Privacy Policy

For more information about Beaumont’s privacy policy, please access https://www.beaumont.org/patients-families/patients-rights-privacy/privacy

For more information about the Academy’s privacy policy, please access http://www.academycme.org/privacy.htm

For questions related to physician credit, contact: cme@beaumont.edu  

For questions related to nursing (including NPs) and PA credit, contact CEservices@academycme.org

Hardware/Software Requirements To access this activity hardware and software requirements are noted below.

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later 
Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later

Copyright 2020 American Academy of CME, Inc., Beaumont Health, and ACTHIV Institute.

Resources: